Earnings Summary

Laboratory Corp. of America Holdings’s revenue fell -9.66% since last year same period to $4056.1Mn in the Q4 2021. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated -0.16% fall in its revenue since last 3-months.

Laboratory Corp. of America Holdings’s net profit fell -41.06% since last year same period to $553Mn in the Q4 2021. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated -5.84% fall in its net profits since last 3-months.

Laboratory Corp. of America Holdings’s net profit margin fell -34.76% since last year same period to 13.63% in the Q4 2021. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated -5.69% fall in its net profit margins since last 3-months.

Laboratory Corp. of America Holdings’s earning per share (EPS) estimates for the current quarter stand at 4.13 - a -11.56% fall from last quarter’s estimates.

Laboratory Corp. of America Holdings’s earning per share (EPS) estimates for the current year stand at 4.13.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Laboratory Corp. of America Holdings’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Laboratory Corp. of America Holdings’s return on equity (ROE) stands at 0.13.

Laboratory Corp. of America Holdings declared 0.72 dividend per share during the earnings announcement for Q4 2022.